Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gene Editing Stock in ARKG Gets Buy Rating By: ETF Trends December 14, 2022 at 04:00 AM EST 2022 hasn’t been a great year for all kinds of tech stocks, and certainly biotech has taken its fair share of lumps as interest rates have continued to dry up funding. That hasn’t stopped the innovation that makes biotech such an appealing space, however. There are still significant steps forward being taken in genetics and [...] The post Gene Editing Stock in ARKG Gets Buy Rating appeared first on ETF Trends . Read More >> Related Stocks: Ark Genomic Revolution ETF Beam Therapeutics Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Gene Editing Stock in ARKG Gets Buy Rating By: ETF Trends December 14, 2022 at 04:00 AM EST 2022 hasn’t been a great year for all kinds of tech stocks, and certainly biotech has taken its fair share of lumps as interest rates have continued to dry up funding. That hasn’t stopped the innovation that makes biotech such an appealing space, however. There are still significant steps forward being taken in genetics and [...] The post Gene Editing Stock in ARKG Gets Buy Rating appeared first on ETF Trends . Read More >> Related Stocks: Ark Genomic Revolution ETF Beam Therapeutics Inc